ChLpMab-23: Cancer-Specific Human–Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular CytotoxicityMika K. Kaneko, Yukinari Kato, Takuro Nakamura et al.|Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|2017Cited by 56
Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of boneMika K. Kaneko, Yukinari Kato, Satoshi Ogasawara et al.|Cancer Science|2014Cited by 44
Development of RAP Tag, a Novel Tagging System for Protein Detection and PurificationYuki Fujii, Yukinari Kato, Mika K. Kaneko et al.|Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|2017Cited by 42
Novel Monoclonal Antibody LpMab-17 Developed by CasMab Technology Distinguishes Human Podoplanin from Monkey PodoplaninYukinari Kato, Mika K. Kaneko, Satoshi Ogasawara et al.|Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|2016Cited by 30
Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent CytotoxicityYukinari Kato, Mika K. Kaneko, Akiko Kunita et al.|Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|2017Cited by 27